Periodontal pathogen accelerates lipid peroxidation and atherosclerosis

Journal of Dental Research

Volumn 92, Issue 3, 2013, Pages 247-252

  Jia, R ^a   Kurita Ochiai, T ^a   Oguchi, S ^a   Yamamoto, M ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

cardiovascular disease; Gram negative bacteria; LDL cholesterol; mice; oxidative stress; periodontal disease

Indexed keywords

ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; CAVEOLIN 1; CELL RECEPTOR; IMMUNOGLOBULIN RECEPTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; LOW DENSITY LIPOPROTEIN; NOS2 PROTEIN, MOUSE; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN PROTEIN; PEROXIDASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TOLL LIKE RECEPTOR;

AGGREGATIBACTER ACTINOMYCETEMCOMITANS; ANIMAL; AORTA; ARTICLE; ATHEROSCLEROSIS; BAGG ALBINO MOUSE; BIOSYNTHESIS; BLOOD; CHEMISTRY; DRUG EFFECT; FEMALE; HEAT; IMMUNOLOGY; INNATE IMMUNITY; LIPID PEROXIDATION; METABOLISM; MICROBIOLOGY; MOUSE; MOUSE MUTANT; OXIDATIVE STRESS; PATHOLOGY; PHYSIOLOGY;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ANIMALS; AORTA; ATHEROSCLEROSIS; CAVEOLIN 1; FEMALE; HOT TEMPERATURE; IMMUNITY, INNATE; LIPID PEROXIDATION; LIPOPOLYSACCHARIDES; LIPOPROTEINS, LDL; MICE; MICE, INBRED BALB C; MICE, MUTANT STRAINS; NADPH OXIDASE; NITRIC OXIDE SYNTHASE TYPE II; NOD SIGNALING ADAPTOR PROTEINS; OXIDATIVE STRESS; PEROXIDASE; REACTIVE OXYGEN SPECIES; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, IMMUNOLOGIC; TOLL-LIKE RECEPTORS;

EID: 84874028211     PISSN: 00220345     EISSN: 15440591     Source Type: Journal    
DOI: 10.1177/0022034513475625     Document Type: Article

References (29)

1. Akalin FA, Baltacioglu E, Alver A, Karabulut E. Lipid peroxidation levels and total oxidant status in serum, saliva and gingival crevicular fluid in patients with chronic periodontitis. J Clin Periodontol. 2007 ; 34: 558-565
2. Bastos AS, Graves DT, Loureiro AP, Rossa Junior C, Abdalla DS, Faulin Tdo E, et al. Lipid peroxidation is associated with the severity of periodontal disease and local inflammatory markers in patients with type 2 diabetes. J Clin Endocrinol Metab. 2012 ; 97: E1353-1362
3. Cai H, Griendling KK, Harrison DG. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol Sci. 2003 ; 24: 471-478
4. Davis BK, Wen H, Ting JP. The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu Rev Immunol. 2011 ; 29: 707-735
5. Figuero E, Sanchez-Beltran M, Cuesta-Frechoso S, Tejerina JM, del Castro JA, Gutierrez JM, et al. Detection of periodontal bacteria in atheromatous plaque by nested polymerase chain reaction. J Periodontol. 2011 ; 82: 1469-1477
6. Fukasawa A, Kurita-Ochiai T, Hashizume T, Kobayashi R, Akimoto Y, Yamamoto M. Porphyromonas gingivalis accelerates atherosclerosis in C57BL/6 mice fed a high-fat diet. Immunopharmacol Immunotoxicol. 2012 ; 34: 470-476
7. Garlet GP, Cardoso CR, Campanelli AP, Ferreira BR, Avila-Campos MJ, Cunha FQ, et al. The dual role of p55 tumor necrosis factor-alpha receptor in Actinobacillus actinomycetemcomitans-induced experimental periodontitis: host protection and tissue destruction. Clin Exp Immunol. 2007 ; 147: 128-138
8. Hansson GK. Inflammatory mechanisms in atherosclerosis. J Thromb Haemost. 2009 ; 7: 328-331
9. Ishigaki Y, Katagiri H, Gao J, Yamada T, Imai J, Uno K, et al. Impact of plasma oxidized low-density lipoprotein removal on atherosclerosis. Circulation. 2008 ; 118: 75-83
10. Johansson A, Eriksson M, Ahren AM, Boman K, Jansson JH, Hallmans G, et al. Prevalence of systemic immunoreactivity to Aggregatibacter actinomycetemcomitans leukotoxin in relation to the incidence of myocardial infarction. BMC Infect Dis. 2011 ; 11: 55
11. Koga T, Nishihara T, Fujiwara T, Nisizawa T, Okahashi N, Noguchi T, et al. Biochemical and immunobiological properties of lipopolysaccharide (LPS) from Bacteroides gingivalis and comparison with LPS from Escherichia coli. Infect Immun. 1985 ; 47: 638-647
12. Koizumi Y, Kurita-Ochiai T, Oguchi S, Yamamoto M. Nasal immunization with Porphyromonas gingivalis outer membrane protein decreases P. gingivalis-induced atherosclerosis and inflammation in spontaneously hyperlipidemic mice. Infect Immun. 2008 ; 76: 2958-2965
13. Kozarov EV, Dorn BR, Shelburne CE, Dunn WA, Progulske-Fox A. Human atherosclerotic plaque contains viable invasive Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis. Arterioscler Thromb Vasc Biol. 2005 ; 25: e17 - e18
14. Lakio L, Lehto M, Tuomainen AM, Jauhiainen M, Malle E, Asikainen S, et al. Pro-atherogenic properties of lipopolysaccharide from the periodontal pathogen Actinobacillus actinomycetemcomitans. J Endotoxin Res. 2006 ; 12: 57-64
15. Lockhart PB, Bolger AF, Papapanou PN, Osinbowale O, Trevisan M, Levison ME, et al. Periodontal disease and atherosclerotic vascular disease: does the evidence support an independent association?: a scientific statement from the American Heart Association. Circulation. 2012 ; 125: 2520-2544
16. Lundberg AM, Hansson GK. Innate immune signals in atherosclerosis. Clin Immunol. 2010 ; 134: 5-24
17. Matsushima Y, Sakurai T, Ohoka A, Ohnuki T, Tada N, Asoh Y, et al. Four strains of spontaneously hyperlipidemic (SHL) mice: phenotypic distinctions determined by genetic backgrounds. J Atheroscler Thromb. 2001 ; 8: 71-79
18. Nakano K, Inaba H, Nomura R, Nemoto H, Tamura K, Miyamoto E, et al. Detection and serotype distribution of Actinobacillus actinomycetemcomitans in cardiovascular specimens from Japanese patients. Oral Microbiol Immunol. 2007 ; 22: 136-139
19. Nicholls SJ, Hazen SL. Myeloperoxidase and cardiovascular disease. Arterioscler Thromb Vasc Biol. 2005 ; 25: 1102-1111
20. Pussinen PJ, Tuomisto K, Jousilahti P, Havulinna AS, Sundvall J, Salomaa V. Endotoxemia, immune response to periodontal pathogens, and systemic inflammation associate with incident cardiovascular disease events. Arterioscler Thromb Vasc Biol. 2007 ; 27: 1433-1439
21. Reddy MA, Li SL, Sahar S, Kim YS, Xu ZG, Lanting L, et al. Key role of Src kinase in S100B-induced activation of the receptor for advanced glycation end products in vascular smooth muscle cells. J Biol Chem. 2006 ; 281: 13685-13693
22. Stocker R, Keaney JF. Role of oxidative modifications in atherosclerosis. Physiol Rev. 2004 ; 84: 1381-1478
23. Stremler KE, Stafforini DM, Prescott SM, Zimmerman GA, McIntyre TM. An oxidized derivative of phosphatidylcholine is a substrate for the platelet-activating factor acetylhydrolase from human plasma. J Biol Chem. 1989 ; 264: 5331-5334
24. Tabibiazar R, Wagner RA, Deng A, Tsao PS, Quertermous T. Proteomic profiles of serum inflammatory markers accurately predict atherosclerosis in mice. Physiol Genomics. 2006 ; 25: 194-202
25. Takahashi Y, Isuzugawa K, Murase Y, Imai M, Yamamoto S, Iizuka M, et al. Up-regulation of NOD1 and NOD2 through TLR4 and TNF-alpha in LPS-treated murine macrophages. J Vet Med Sci. 2006 ; 68: 471-478
26. Tuomainen AM, Jauhiainen M, Kovanen PT, Metso J, Paju S, Pussinen PJ. Aggregatibacter actinomycetemcomitans induces MMP-9 expression and proatherogenic lipoprotein profile in apoE-deficient mice. Microb Pathog. 2008 ; 44: 111-117
27. Uchida K. 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. Prog Lipid Res. 2003 ; 42: 318-343
28. Yun JH, Park SJ, Jo A, Kang JL, Jou I, Park JS, et al. Caveolin-1 is involved in reactive oxygen species-induced SHP-2 activation in astrocytes. Exp Mol Med. 2011 ; 43: 660-668
29. Zhang T, Kurita-Ochiai T, Hashizume T, Du Y, Oguchi S, Yamamoto M. Aggregatibacter actinomycetemcomitans accelerates atherosclerosis with an increase in atherogenic factors in spontaneously hyperlipidemic mice. FEMS Immunol Med Microbiol. 2010 ; 59: 143-151